title: Importance of pacemaker noise reversion as a potential mechanism of pacemaker-ICD interactions.
abstract: Numerous types of interactions between pacemakers and implantable cardioverter defibrillators (ICDs) have been described. Pacemaker outputs preventing appropriate detection of ventricular tachycardia or ventricular fibrillation by the ICD is one of the more serious. Asynchronous pacemaker activity during ventricular arrhythmias may be caused by either nonsensing of the arrhythmia or by noise reversion, which is an algorithm that causes the pacemaker to switch to asynchronous pacing when repetitive sensing at a high rate occurs. We analyzed the mechanisms underlying asynchronous pacemaker activity in ventricular arrhythmias using pacemaker telemetry during the arrhythmia. Thirty-nine induced arrhythmias from 26 different procedures in 19 patients with both pacemakers and ICDs were analyzed. Of the 39 arrhythmias, asynchronous pacemaker activity occurred in 16. The underlying mechanism was nonsensing in 4 episodes and noise reversion in 12 episodes. Clinically significant interference with detection arose on three occasions. Conditions favoring the occurrence of noise reversion include specific pacemaker models, arrhythmia cycle lengths in the range causing noise reversion of the individual pacemaker model, long noise sampling periods, and VVI pacing mode. Noise reversion can be diagnosed by telemetering the pacemaker marker channel during ventricular arrhythmias as a part of routine pacemaker-ICD interaction evaluation. It can be prevented or minimized by programming short ventricular refractory periods or using pacemakers with short retriggerable refractory periods.
authors.affiliation: Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA. mglikson@post.tau.ac.il
authors.forename: M
authors.initials: M
authors.lastname: Glikson
authors.forename: J M
authors.initials: JM
authors.lastname: Trusty
authors.forename: S K
authors.initials: SK
authors.lastname: Grice
authors.forename: D L
authors.initials: DL
authors.lastname: Hayes
authors.forename: S C
authors.initials: SC
authors.lastname: Hammill
authors.forename: M S
authors.initials: MS
authors.lastname: Stanton
mesh_terms: D001919:Bradycardia / Q000628:therapy; D017147:Defibrillators, Implantable / Q000009:adverse effects; D004560:Electricity; D004562:Electrocardiography; D004567:Electrodes, Implanted; D004868:Equipment Failure; D005069:Evaluation Studies as Topic; D006801:Humans; D010138:Pacemaker, Artificial / Q000009:adverse effects; D011446:Prospective Studies; D017180:Tachycardia, Ventricular / Q000628:therapy*